Pin to quick picksAstrazeneca Regulatory News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price: 7,324.00
Bid: 7,325.00
Ask: 7,327.00
Change: -88.00 (-1.19%)
Spread: 2.00 (0.03%)
Open: 7,427.00
High: 7,479.00
Low: 7,304.00
Yest. Close: 7,412.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.
Date   Source Headline
22nd Aug 20197:00 amRNSAstraZeneca PLC - Roxadustat approved in China for the treatment of
22nd Aug 20197:00 amRNSAstraZeneca PLC - AstraZeneca agrees to buy US FDA Priority Review
21st Aug 20197:00 amRNSAstraZeneca PLC - Update on the Phase III NEPTUNE trial
20th Aug 20197:00 amRNSAstraZeneca PLC - Farxiga met primary endpoint in landmark Phase III
19th Aug 20197:00 amRNSAstraZeneca PLC - Directorate Change
14th Aug 20197:00 amRNSAstraZeneca PLC - Calquence granted US Breakthrough Therapy Designat
14th Aug 20197:00 amRNSAstraZeneca PLC - Lynparza Phase III PAOLA-1 trial met primary endpo
9th Aug 20199:28 amRNSAstraZeneca PLC - Amendment: Tagrisso significantly improves overall
9th Aug 20197:00 amRNSAstraZeneca PLC - Tagrisso significantly improves overall survival
7th Aug 20197:00 amRNSAstraZeneca PLC - Lynparza Phase III PROfound trial in HRR*
5th Aug 20197:00 amRNSAstraZeneca PLC - Forxiga label updated in the EU in type-2 diabetes
1st Aug 20193:00 pmRNSAstraZeneca PLC - Total Voting Rights
25th Jul 20197:00 amRNSAstraZeneca PLC - AZN: H1 2019 Results
15th Jul 20197:00 amRNSAstraZeneca PLC - Update on US regulatory decision for Farxiga
12th Jul 20197:00 amRNSAstraZeneca PLC - Imfinzi granted US Orphan Drug Designation for
1st Jul 20193:00 pmRNSAstraZeneca PLC - Total Voting Rights
1st Jul 20197:00 amRNSAstraZeneca PLC - Forxiga receives positive EU CHMP opinion for
1st Jul 20197:00 amRNSAstraZeneca PLC - Fasenra receives positive EU CHMP opinion for self
27th Jun 20197:00 amRNSAstraZeneca PLC - Imfinzi improves overall survival at interim
19th Jun 20197:00 amRNSAstraZeneca PLC - Breztri Aerosphere (PT010) approved in Japan for
19th Jun 20197:00 amRNSAstraZeneca PLC - Lynparza approved in Japan for 1st-line
19th Jun 20197:00 amRNSAstraZeneca PLC - Bevespi Aerosphere approved by the Japanese
18th Jun 20197:00 amRNSAstraZeneca PLC - Lynparza approved in the EU for 1st-line
17th Jun 20197:00 amRNSAstraZeneca PLC - Calquence significantly prolonged the time patient
12th Jun 20194:45 pmRNSAstraZeneca PLC - Publication of a Prospectus
6th Jun 20197:00 amRNSAstraZeneca PLC - Calquence Phase III ELEVATE-TN trial met primary
3rd Jun 20193:00 pmRNSAstraZeneca PLC - Block listing Interim Review
3rd Jun 20193:00 pmRNSAstraZeneca PLC - Total Voting Rights
3rd Jun 20197:00 amRNSAstraZeneca PLC - Lynparza nearly doubled time patients lived with
10th May 20197:00 amRNSAstraZeneca PLC - Pooled analyses of the roxadustat global Phase III
8th May 20192:00 pmRNSAstraZeneca PLC - Director/PDMR Shareholding
8th May 201911:00 amRNSAstraZeneca PLC - Director Declaration
8th May 20197:00 amRNSAstraZeneca PLC - Trastuzumab deruxtecan demonstrated clinically
7th May 20197:00 amRNSAstraZeneca PLC - Calquence PhIII ASCEND trial met primary endpoint
3rd May 20197:00 amRNSAstraZeneca PLC - Qternmet XR approved in the US for type-2 diabetes
1st May 20193:00 pmRNSAstraZeneca PLC - Total Voting Rights
1st May 201912:00 pmRNSAstraZeneca PLC - Director/PDMR Shareholding
29th Apr 20197:00 amRNSAstraZeneca PLC - Lynparza receives positive EU CHMP opinion for 1st
26th Apr 20195:45 pmRNSAstraZeneca PLC - Result of AGM
26th Apr 20197:00 amRNSAstraZeneca PLC - AZN: Q1 2019 Results
10th Apr 20197:00 amRNSAstraZeneca PLC - Lynparza approved in EU for the treatment of germl
4th Apr 20191:30 pmRNSAstraZeneca PLC - Holding(s) in Company
3rd Apr 201910:00 amRNSAstraZeneca PLC - Director/PDMR Shareholding
2nd Apr 20193:00 pmRNSAstraZeneca PLC - Total Voting Rights
1st Apr 20196:00 pmRNSFTSE Russell - Astrazeneca
1st Apr 20193:00 pmRNSAstraZeneca PLC - Total Voting Rights
1st Apr 20197:00 amRNSAstraZeneca PLC - Selumetinib gets Breakthrough Therapy Designation
29th Mar 20195:15 pmRNSAstraZeneca PLC - Results of Placing
29th Mar 20197:00 amRNSAstraZeneca PLC - Proposed placing of new ordinary shares
29th Mar 20197:00 amRNSAstraZeneca PLC - AZ and Daiichi Sankyo enter collaboration in novel

Login to your account

Don't have an account? Click here to register.